Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma
The findings suggest that immunotherapy is efficacious and safe for treating RM-NPC in elderly patients. The combination of ICIs and local therapy significantly prolonged survival and could be an option for this vulnerable population.
Authors
- Yan‐Feng Ouyang
- Ruiling Xie (ORCID: https://orcid.org/0000-0002-6086-8683)
- Rui Sun (ORCID: https://orcid.org/0000-0002-8484-8089)
- Wu-Lin Cai
- Ye-Hao Zou
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1186/s12885-025-14108-w
- Citations
- 3
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.54
Funders
- Sun Yat-sen University
- China Postdoctoral Science Foundation
- Natural Science Foundation of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province